PLEASANTON, Calif., Aug. 22,
2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq:
TXG), a leader in single cell and spatial biology, announced today
that members of its management team will participate in a fireside
chat at the Morgan Stanley 22nd Annual Global Healthcare
Conference on Wednesday, September 4,
at 10:45 a.m. Eastern Time.
Interested parties may access a live webcast of the fireside
chat on the "Investors" section of the company's website at:
https://investors.10xgenomics.com/. The webcast will be archived
and available for replay for at least 45 days after the event.
About 10x Genomics
10x Genomics is a life science
technology company building products to accelerate the mastery of
biology and advance human health. Our integrated solutions include
instruments, consumables and software for single cell and spatial
biology, which help academic and translational researchers and
biopharmaceutical companies understand biological systems at a
resolution and scale that matches the complexity of biology. Our
products are behind breakthroughs in oncology, immunology,
neuroscience and more, fueling powerful discoveries that are
transforming the world's understanding of health and disease. To
learn more, visit 10xgenomics.com or connect with us on LinkedIn or
X (Twitter).
Disclosure Information
10x Genomics uses filings with
the Securities and Exchange Commission, our website
(www.10xgenomics.com), press releases, public conference calls,
public webcasts and our social media accounts as means of
disclosing material non-public information and for complying with
our disclosure obligations under Regulation FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-present-at-the-morgan-stanley-22nd-annual-global-healthcare-conference-302228910.html
SOURCE 10x Genomics, Inc.